awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33632656-52DAC6DD-761E-4980-9817-BF8A915380CC
Q33632656-52DAC6DD-761E-4980-9817-BF8A915380CC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33632656-52DAC6DD-761E-4980-9817-BF8A915380CC
Advanced non-small cell lung cancer: on relapse rechallenge the tumor, not the patient.
P2860
Q33632656-52DAC6DD-761E-4980-9817-BF8A915380CC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33632656-52DAC6DD-761E-4980-9817-BF8A915380CC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b4c36e726732ee52ca640f876a983777600d1a93
P2860
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.